Altimmune, Inc. (ALT)
USD 4.27
(-4.37%)
USD 4.27
(-4.37%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -134.48 Million USD | -22.29% |
| 2022 | -109.97 Million USD | 41.74% |
| 2021 | -188.76 Million USD | -65.45% |
| 2020 | -114.09 Million USD | -1480.55% |
| 2019 | -7.21 Million USD | 78.22% |
| 2018 | -33.14 Million USD | -280.12% |
| 2017 | -8.71 Million USD | 94.3% |
| 2016 | -153.01 Million USD | -956.2% |
| 2015 | -14.48 Million USD | 19.06% |
| 2014 | -17.89 Million USD | -133.68% |
| 2013 | -7.65 Million USD | 14.11% |
| 2012 | -8.91 Million USD | 20.65% |
| 2011 | -11.23 Million USD | 4.65% |
| 2010 | -11.78 Million USD | -179.88% |
| 2009 | 14.75 Million USD | 1119.71% |
| 2008 | -1.44 Million USD | 92.73% |
| 2007 | -19.91 Million USD | -2848.92% |
| 2006 | -675.3 Thousand USD | 51.7% |
| 2005 | -1.39 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -78.46 Million USD | 41.65% |
| 2024 Q2 | -55.3 Million USD | 29.57% |
| 2023 Q4 | -134.48 Million USD | -56.26% |
| 2023 Q3 | -86.06 Million USD | 15.16% |
| 2023 Q1 | -103.67 Million USD | 5.73% |
| 2023 Q2 | -101.44 Million USD | 2.15% |
| 2023 FY | -134.48 Million USD | -22.29% |
| 2022 Q3 | -126.23 Million USD | 6.16% |
| 2022 Q2 | -134.52 Million USD | 24.64% |
| 2022 FY | -109.97 Million USD | 41.74% |
| 2022 Q1 | -178.51 Million USD | 5.43% |
| 2022 Q4 | -109.97 Million USD | 12.88% |
| 2021 FY | -188.76 Million USD | -65.45% |
| 2021 Q1 | -148.19 Million USD | -29.89% |
| 2021 Q2 | -172.45 Million USD | -16.37% |
| 2021 Q3 | -173.23 Million USD | -0.45% |
| 2021 Q4 | -188.76 Million USD | -8.97% |
| 2020 FY | -114.09 Million USD | -1480.55% |
| 2020 Q1 | -9.59 Million USD | -32.89% |
| 2020 Q4 | -114.09 Million USD | 19.43% |
| 2020 Q2 | -62.49 Million USD | -551.43% |
| 2020 Q3 | -141.6 Million USD | -126.6% |
| 2019 Q1 | -41.81 Million USD | -26.16% |
| 2019 Q3 | -9.06 Million USD | 76.99% |
| 2019 FY | -7.21 Million USD | 78.22% |
| 2019 Q4 | -7.21 Million USD | 20.35% |
| 2019 Q2 | -39.39 Million USD | 5.8% |
| 2018 Q4 | -33.14 Million USD | -456.89% |
| 2018 FY | -33.14 Million USD | -280.12% |
| 2018 Q1 | -4.51 Million USD | 44.45% |
| 2018 Q2 | -2.27 Million USD | 49.53% |
| 2018 Q3 | -5.95 Million USD | -161.5% |
| 2017 Q1 | -11.43 Million USD | 92.55% |
| 2017 Q4 | -8.11 Million USD | 50.72% |
| 2017 Q3 | -16.47 Million USD | -112.67% |
| 2017 Q2 | -7.74 Million USD | 32.27% |
| 2017 FY | -8.71 Million USD | 94.3% |
| 2016 Q3 | -68 Million USD | -193.67% |
| 2016 Q4 | -153.49 Million USD | -125.7% |
| 2016 Q1 | -14.23 Million USD | 1.73% |
| 2016 FY | -153.01 Million USD | -956.2% |
| 2016 Q2 | -23.15 Million USD | -62.68% |
| 2015 Q4 | -14.48 Million USD | 16.69% |
| 2015 Q2 | -18.16 Million USD | -19.28% |
| 2015 Q3 | -17.38 Million USD | 4.26% |
| 2015 FY | -14.48 Million USD | 19.06% |
| 2015 Q1 | -15.22 Million USD | 14.92% |
| 2014 FY | -17.89 Million USD | -133.68% |
| 2014 Q3 | -18.62 Million USD | -85.8% |
| 2014 Q4 | -17.89 Million USD | 3.92% |
| 2014 Q1 | -8.04 Million USD | -5.1% |
| 2014 Q2 | -10.02 Million USD | -24.55% |
| 2013 Q3 | -13.96 Million USD | -12.62% |
| 2013 Q2 | -12.4 Million USD | -36.55% |
| 2013 Q1 | -9.08 Million USD | -1.87% |
| 2013 FY | -7.65 Million USD | 14.11% |
| 2013 Q4 | -7.65 Million USD | 45.17% |
| 2012 FY | -8.91 Million USD | 20.65% |
| 2012 Q4 | -8.91 Million USD | 19.46% |
| 2012 Q3 | -11.07 Million USD | -18.56% |
| 2012 Q2 | -9.33 Million USD | 22.28% |
| 2012 Q1 | -12.01 Million USD | -6.94% |
| 2011 FY | -11.23 Million USD | 4.65% |
| 2011 Q4 | -11.23 Million USD | -7.98% |
| 2011 Q3 | -10.4 Million USD | 26.51% |
| 2011 Q2 | -14.16 Million USD | -45.86% |
| 2011 Q1 | -9.7 Million USD | 17.62% |
| 2010 Q1 | 17.54 Million USD | 18.95% |
| 2010 Q3 | 17.34 Million USD | -6.16% |
| 2010 Q4 | -11.78 Million USD | -167.97% |
| 2010 FY | -11.78 Million USD | -179.88% |
| 2010 Q2 | 18.47 Million USD | 5.3% |
| 2009 Q4 | 14.75 Million USD | 19.06% |
| 2009 FY | 14.75 Million USD | 1119.71% |
| 2009 Q1 | 531.33 Thousand USD | 136.73% |
| 2009 Q2 | 7.98 Million USD | 1402.44% |
| 2009 Q3 | 12.39 Million USD | 55.23% |
| 2008 Q1 | 755.44 Thousand USD | 103.79% |
| 2008 FY | -1.44 Million USD | 92.73% |
| 2008 Q4 | -1.44 Million USD | -116.64% |
| 2008 Q3 | 8.69 Million USD | 65.81% |
| 2008 Q2 | 5.24 Million USD | 594.32% |
| 2007 Q2 | 12.5 Million USD | 2774.44% |
| 2007 Q1 | -467.38 Thousand USD | -104.2% |
| 2007 FY | -19.91 Million USD | -2848.92% |
| 2007 Q4 | -19.91 Million USD | 48.49% |
| 2007 Q3 | -38.65 Million USD | -409.27% |
| 2006 Q3 | -763.93 Thousand USD | 23.83% |
| 2006 Q1 | -1.32 Million USD | 5.4% |
| 2006 FY | -675.3 Thousand USD | 51.7% |
| 2006 Q4 | 11.12 Million USD | 1556.24% |
| 2006 Q2 | -1 Million USD | 24.17% |
| 2005 Q2 | 169.24 Thousand USD | 0.0% |
| 2005 FY | -1.39 Million USD | 0.0% |
| 2005 Q4 | -1.39 Million USD | 4.97% |
| 2005 Q3 | -1.47 Million USD | -969.4% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -140.413% |
| Alkermes plc | -166.73 Million USD | 19.343% |
| Agenus Inc. | 274.13 Million USD | 149.058% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 107.192% |
| Aptorum Group Limited | 1.35 Million USD | 10010.276% |
| Ardelyx, Inc. | 34.51 Million USD | 489.682% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 3242.22% |
| Bicycle Therapeutics plc | -481.46 Million USD | 72.067% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 471.891% |
| ChromaDex Corporation | -24.04 Million USD | -459.244% |
| Chimerix, Inc. | -25.51 Million USD | -427.049% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2030.045% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -468.007% |
| CRISPR Therapeutics AG | -150.84 Million USD | 10.844% |
| Precision BioSciences, Inc. | -85.41 Million USD | -57.46% |
| Dyadic International, Inc. | -6.37 Million USD | -2008.575% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -744.078% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1854.56% |
| Lantern Pharma Inc. | -21.7 Million USD | -519.662% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -21.667% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1474.204% |
| Incyte Corporation | -3.17 Billion USD | 95.764% |
| IO Biotech, Inc. | -140.69 Million USD | 4.415% |
| Jaguar Health, Inc. | 29.39 Million USD | 557.579% |
| Novavax, Inc. | -298.29 Million USD | 54.915% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 2619.899% |
| Opthea Limited | 28.15 Million USD | 577.625% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -701.042% |
| ContextLogic Inc. | -232 Million USD | 42.031% |
| MiMedx Group, Inc. | -33.9 Million USD | -296.705% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1419.147% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -5704.291% |
| NextCure, Inc. | -6.47 Million USD | -1976.378% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -166.306% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2008.277% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1205.682% |
| Vaxcyte, Inc. | -368.22 Million USD | 63.477% |
| PDS Biotechnology Corporation | -32.7 Million USD | -311.163% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 878.371% |
| Pharming Group N.V. | 109.8 Million USD | 222.479% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -673.092% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 23.251% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -626.177% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -626.177% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -1794.183% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2195.0% |
| Acelyrin, Inc. | -216.9 Million USD | 37.997% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -2297.159% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -7700.87% |
| Summit Therapeutics Inc. | 34.67 Million USD | 487.861% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -1876.878% |
| Senti Biosciences, Inc. | 1.74 Million USD | 7829.138% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 27.15% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -73.641% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -2118.525% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 134898.384% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 21515.127% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -14.901% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 20.059% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 221.302% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -1670.498% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -4.161% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2050.614% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 44.51% |
| Immix Biopharma, Inc. | -17.5 Million USD | -668.067% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 57.535% |
| MEI Pharma, Inc. | -3.7 Million USD | -3529.879% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1174.95% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 183.149% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 583.888% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1854.56% |
| Precigen, Inc. | -481 Thousand USD | -27859.875% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1055.096% |
| AlloVir, Inc. | -62.69 Million USD | -114.52% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -141.822% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 318.089% |
| ImmuCell Corporation | 10.99 Million USD | 1323.659% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 12.753% |
| Onconetix, Inc. | 5.33 Million USD | 2622.528% |
| PureTech Health plc | -167.19 Million USD | 19.564% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -341.52% |
| Elevation Oncology, Inc. | -19.11 Million USD | -603.457% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -2639.601% |
| Seer, Inc. | -4.24 Million USD | -3071.863% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -459.5% |
| Innoviva, Inc. | 255.56 Million USD | 152.624% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -140.74% |
| ESSA Pharma Inc. | -33.62 Million USD | -300.002% |
| GlycoMimetics, Inc. | -40.98 Million USD | -228.142% |
| GT Biopharma, Inc. | -1.02 Million USD | -13072.086% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -98.408% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 319.546% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -0.304% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -870.605% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -365.804% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -178420.987% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -335.769% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1541.115% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -4198.058% |
| Soligenix, Inc. | -4.95 Million USD | -2616.033% |
| Century Therapeutics, Inc. | 847 Thousand USD | 15978.04% |
| Kura Oncology, Inc. | -20.11 Million USD | -568.491% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -228.61% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1501.417% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 7482.52% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -4106.662% |
| Autolus Therapeutics plc | -186.59 Million USD | 27.927% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -172.771% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 51.236% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 492.457% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 181.821% |
| GRI Bio, Inc. | -1.79 Million USD | -7396.488% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1397.12% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -304.387% |
| IGM Biosciences, Inc. | -72.6 Million USD | -85.228% |
| INmune Bio, Inc. | -25.41 Million USD | -429.247% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 189.093% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -165.475% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -727.644% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -4561.714% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 453.774% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -226.544% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 521.788% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 135.583% |
| Verastem, Inc. | -37.27 Million USD | -260.768% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1382.277% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -159.317% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -788.583% |
| Histogen Inc. | -7.48 Million USD | -1696.274% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -522.428% |
| Surrozen, Inc. | -32.66 Million USD | -311.729% |
| Organovo Holdings, Inc. | -1.5 Million USD | -8824.154% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3099.414% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 809.312% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 5240.94% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 3335.972% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1504.637% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -209.578% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -822.606% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 57.547% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -18525.46% |
| Apollomics, Inc. | -27.39 Million USD | -390.918% |
| Amarin Corporation plc | -191.04 Million USD | 29.603% |
| Mesoblast Limited | 55.96 Million USD | 340.314% |
| Turnstone Biologics Corp. | -14.58 Million USD | -822.154% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -431.737% |
| Synaptogenix, Inc. | -28.66 Million USD | -369.225% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -14268.269% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 375.973% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -15500.129% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1750.888% |
| Exelixis, Inc. | -73.05 Million USD | -84.103% |
| Better Therapeutics, Inc. | -860 Thousand USD | -15538.023% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -460.059% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 44.282% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 18371.052% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1708.074% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 10824.641% |
| Gritstone bio, Inc. | 39.49 Million USD | 440.56% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -59.911% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -5009.417% |
| Avid Bioservices, Inc. | 169.72 Million USD | 179.237% |
| Insmed Incorporated | 721.62 Million USD | 118.637% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1371.168% |
| MediWound Ltd. | -5.32 Million USD | -2427.001% |
| OmniAb, Inc. | 9.2 Million USD | 1561.339% |
| Alector, Inc. | -35.63 Million USD | -277.38% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 256.433% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -2629.038% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1115.84% |
| Zai Lab Limited | -775 Million USD | 82.647% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 139.491% |
| Aura Biosciences, Inc. | -21.52 Million USD | -524.794% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -63.054% |
| Immunic, Inc. | -45.34 Million USD | -196.619% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 30.395% |
| Veracyte, Inc. | -203.82 Million USD | 34.018% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 121.07% |
| FibroGen, Inc. | 56.76 Million USD | 336.911% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1610.241% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -4657.096% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -6395.864% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 102.93% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -3925.352% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 18.966% |
| TG Therapeutics, Inc. | 17.86 Million USD | 852.922% |
| Galecto, Inc. | -21.21 Million USD | -533.894% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -465.428% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 108.569% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -449.555% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1068.741% |
| XBiotech Inc. | -200.02 Million USD | 32.764% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -59.911% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 3070.119% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -281.383% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -74.165% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 2463.152% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 21.083% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -45.59% |
| Vaxxinity, Inc. | 10.13 Million USD | 1427.349% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 118.266% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1149.003% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -103.904% |
| NexImmune, Inc. | -3.13 Million USD | -4191.714% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -3795.156% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -789.968% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -396.262% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1398.287% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -107856.653% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -231.477% |
| Ainos, Inc. | 4.07 Million USD | 3397.925% |
| Pluri Inc. | 22.82 Million USD | 689.106% |
| Prothena Corporation plc | -608.34 Million USD | 77.893% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -13.246% |
| Celularity Inc. | 65.19 Million USD | 306.3% |
| Rallybio Corporation | -24.1 Million USD | -457.991% |
| Cue Biopharma, Inc. | -33.81 Million USD | -297.667% |
| MeiraGTx Holdings plc | -40.3 Million USD | -233.698% |
| Omeros Corporation | 331.17 Million USD | 140.609% |
| Humacyte, Inc. | -22.48 Million USD | -498.092% |
| Immunocore Holdings plc | -358.59 Million USD | 62.496% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -447.251% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -335.219% |
| Blueprint Medicines Corporation | 702.83 Million USD | 119.135% |
| CalciMedica, Inc. | -5.53 Million USD | -2331.953% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 28.548% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1216.693% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -235.907% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -304.436% |
| Pulmatrix, Inc. | -10.41 Million USD | -1191.034% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2150.075% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -252.596% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -20.722% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -124.354% |
| Cytokinetics, Incorporated | 642.37 Million USD | 120.936% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -2209.583% |
| Nutriband Inc. | -251.65 Thousand USD | -53340.596% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -294.17% |
| Vor Biopharma Inc. | 4.3 Million USD | 3227.605% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.772% |
| Evogene Ltd. | -19.63 Million USD | -584.97% |
| ProKidney Corp. | -56.23 Million USD | -139.148% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -176.313% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1355.93% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 109.86% |
| CorMedix Inc. | -43.05 Million USD | -212.379% |
| BioLineRx Ltd. | 7.33 Million USD | 1933.247% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -389.667% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 391.432% |
| Atai Life Sciences N.V. | -28.55 Million USD | -370.926% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 6129.377% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -489.442% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 858.314% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -79.139% |
| MediciNova, Inc. | -50.78 Million USD | -164.824% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -70.658% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -597752.856% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1984.233% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 32.696% |
| Biomea Fusion, Inc. | -166.57 Million USD | 19.261% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 24.857% |
| Mereo BioPharma Group plc | -51.46 Million USD | -161.297% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -41.798% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 54.219% |
| Absci Corporation | -72.59 Million USD | -85.249% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3045.401% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 42.634% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -42.751% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -40.536% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -244.194% |
| Allakos Inc. | -24.97 Million USD | -438.486% |
| Imunon, Inc. | -4.21 Million USD | -3091.545% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -812.271% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 0.674% |
| BioAtla, Inc. | -109.01 Million USD | -23.37% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 18371.052% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -14222.364% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1223.909% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -534.283% |
| XOMA Corporation | -29 Million USD | -363.748% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -712.12% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1391.648% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1705.437% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -7.904% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 35.394% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -64.452% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -44.979% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -15552.875% |
| Akari Therapeutics, Plc | -3.84 Million USD | -3397.711% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 8386.883% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 109.739% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -11219.168% |
| UroGen Pharma Ltd. | 4.39 Million USD | 3162.788% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 218.511% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 186986.134% |
| Orgenesis Inc. | 21.78 Million USD | 717.366% |
| Entera Bio Ltd. | -10.62 Million USD | -1165.284% |
| GH Research PLC | -78.07 Million USD | -72.249% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -503.405% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -404.471% |
| Xencor, Inc. | 29.64 Million USD | 553.674% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -6727.403% |
| Replimune Group, Inc. | 1.41 Million USD | 9624.575% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -54813.274% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -6.384% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -11219.168% |
| Portage Biotech Inc. | -4.98 Million USD | -2600.0% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -597752.856% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -103.392% |
| OncoCyte Corporation | -6.56 Million USD | -1949.17% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 15086.077% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -2852.097% |
| Purple Biotech Ltd. | -14.13 Million USD | -851.245% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -466.118% |
| scPharmaceuticals Inc. | -6.54 Million USD | -1954.805% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -705.689% |
| HilleVax, Inc. | -165.48 Million USD | 18.732% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -5198.936% |
| Tharimmune, Inc. | -10.93 Million USD | -1129.837% |
| Genprex, Inc. | -6.73 Million USD | -1896.058% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 63.535% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -52.031% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -9499.358% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -3954.543% |
| OKYO Pharma Limited | -826.84 Thousand USD | -16165.021% |
| Savara Inc. | 153 Thousand USD | 88000.0% |
| Curis, Inc. | -23.88 Million USD | -463.013% |
| Daré Bioscience, Inc. | -5.15 Million USD | -2507.393% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -17230.531% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2066.35% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 11449.114% |
| BeiGene, Ltd. | -2.25 Billion USD | 94.031% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1189.979% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 77.888% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 27.534% |
| Erasca, Inc. | -37.21 Million USD | -261.369% |
| bluebird bio, Inc. | 108.57 Million USD | 223.87% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -10342.405% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 135.508% |
| DBV Technologies S.A. | -126.98 Million USD | -5.907% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -10342.405% |
| Moderna, Inc. | -2.9 Billion USD | 95.374% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1199.14% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1137.459% |
| Molecular Templates, Inc. | 707 Thousand USD | 19122.207% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -328.698% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 138.801% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -63.885% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -46.612% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -316.73% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -291.224% |
| MacroGenics, Inc. | -66.98 Million USD | -100.772% |
| RenovoRx, Inc. | -1.17 Million USD | -11365.217% |
| Adicet Bio, Inc. | -138.78 Million USD | 3.098% |
| Prime Medicine, Inc. | -27.94 Million USD | -381.325% |
| Aditxt, Inc. | 18.12 Million USD | 842.166% |
| Adagene Inc. | -87.62 Million USD | -53.476% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3128.648% |
| Quantum-Si incorporated | -118.55 Million USD | -13.437% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 473.523% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1699.353% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -177.241% |
| SciSparc Ltd. | -2.06 Million USD | -6412.688% |
| Vericel Corporation | 1.27 Million USD | 10631.48% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1021.501% |
| Minerva Neurosciences, Inc. | 41 Million USD | 427.983% |
| Generation Bio Co. | 31.44 Million USD | 527.649% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 23.31% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -334.909% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 215.347% |
| Invivyd, Inc. | -198.47 Million USD | 32.24% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -48.983% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -5509.028% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -89.98% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -1870.505% |
| 2seventy bio, Inc. | 181.71 Million USD | 174.01% |
| ADMA Biologics, Inc. | 90.06 Million USD | 249.32% |
| Clene Inc. | 3.34 Million USD | 4126.557% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1380.694% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -525.201% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1984.233% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 60.919% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -417.264% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 175.697% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -3186.931% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 2788.665% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -2481.82% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -3.21% |
| Evaxion Biotech A/S | 5.28 Million USD | 2643.805% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -19.472% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -2.448% |
| Trevena, Inc. | 2.25 Million USD | 6056.023% |
| Surrozen, Inc. | -32.66 Million USD | -311.729% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -161.089% |
| Cingulate Inc. | 3.08 Million USD | 4462.661% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -4479.06% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 1971.254% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1347.462% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -69.544% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -2.309% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -27.425% |
| Clearmind Medicine Inc. | -3.94 Million USD | -3311.093% |
| Kronos Bio, Inc. | -36.05 Million USD | -273.015% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1529.344% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 9323.271% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -147.875% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1032.875% |
| ImmunityBio, Inc. | 618.22 Million USD | 121.754% |
| Korro Bio, Inc. | -132.94 Million USD | -1.161% |
| Kineta, Inc. | -4.54 Million USD | -2861.616% |
| BioVie Inc. | -17.73 Million USD | -658.427% |
| Codexis, Inc. | -43.27 Million USD | -210.802% |
| Celularity Inc. | 65.19 Million USD | 306.3% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -4143.831% |
| Celcuity Inc. | 6.78 Million USD | 2082.558% |
| Virax Biolabs Group Limited | -3.36 Million USD | -3896.708% |
| Cibus, Inc. | -8.07 Million USD | -1564.855% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -3080.114% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 3042.823% |
| IN8bio, Inc. | -16.38 Million USD | -720.593% |
| Kodiak Sciences Inc. | -103.87 Million USD | -29.47% |
| Annexon, Inc. | -193.75 Million USD | 30.589% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 373675.0% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -668.541% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -3728.266% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 112.756% |
| Eyenovia, Inc. | 1.25 Million USD | 10784.578% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 599.859% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -4046.994% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -304.509% |
| Arcellx, Inc. | -296.95 Million USD | 54.712% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -589.465% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -128.428% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -548.849% |
| Moolec Science SA | 117.61 Thousand USD | 114444.137% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -250.236% |
| Geron Corporation | 14.76 Million USD | 1011.097% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -254.679% |
| Royalty Pharma plc | 5.65 Billion USD | 102.377% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 4.903% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -1824.15% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -2407.748% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 4.437% |
| Humacyte, Inc. | -22.48 Million USD | -498.092% |
| Structure Therapeutics Inc. | -124.33 Million USD | -8.162% |
| 89bio, Inc. | -289.05 Million USD | 53.473% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -432.791% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -7442.737% |
| Genelux Corporation | -6.89 Million USD | -1849.369% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -333.005% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 260.872% |
| Notable Labs, Ltd. | -9.77 Million USD | -1275.685% |
| Liquidia Corporation | -80.17 Million USD | -67.74% |
| Mustang Bio, Inc. | -3.73 Million USD | -3499.759% |
| Immunovant, Inc. | -635.22 Million USD | 78.829% |
| Quantum-Si incorporated | -118.55 Million USD | -13.437% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -665.697% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -3146.126% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1775.433% |
| Acasti Pharma Inc. | -23 Million USD | -484.599% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -3893.996% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -727.644% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 2.362% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -4215.513% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -504.925% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -624.255% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 20.553% |
| PepGen Inc. | -60.67 Million USD | -121.67% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -485.337% |
| United Therapeutics Corporation | -507.7 Million USD | 73.511% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -603.163% |
| Solid Biosciences Inc. | -47.75 Million USD | -181.648% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -15500.129% |
| Immuneering Corporation | -54.94 Million USD | -144.776% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3099.414% |
| Silo Pharma, Inc. | -3.52 Million USD | -3715.983% |
| Belite Bio, Inc | -87.27 Million USD | -54.103% |
| XOMA Corporation | -29 Million USD | -363.748% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -90.23% |
| Bionomics Limited | 227 Million USD | 159.243% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -15.656% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5209.396% |
| uniQure N.V. | -102.95 Million USD | -30.632% |
| Cassava Sciences, Inc. | -121.13 Million USD | -11.021% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3128.648% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 428.41% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1024.379% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -4246.422% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 126974.528% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -4046.994% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1610.241% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1713.471% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 167.9% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5209.396% |
| Compugen Ltd. | -12.9 Million USD | -942.212% |
| Peak Bio, Inc. | 10.34 Million USD | 1400.628% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -47421.908% |
| Benitec Biopharma Inc. | -50.58 Million USD | -165.879% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -28.896% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 784.586% |
| Zura Bio Limited | -99.8 Million USD | -34.748% |
| PolyPid Ltd. | 6.17 Million USD | 2279.692% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 281.445% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 784.586% |
| Instil Bio, Inc. | 75.35 Million USD | 278.464% |
| argenx SE | -2.02 Billion USD | 93.371% |
| Immunome, Inc. | -97.02 Million USD | -38.605% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -497.853% |
| Verona Pharma plc | -220.44 Million USD | 38.992% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -87.457% |
| Shattuck Labs, Inc. | -121.42 Million USD | -10.758% |
| CervoMed Inc. | -7.79 Million USD | -1625.775% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 27.5% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -2975.394% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -2.085% |
| Moolec Science SA | 117.61 Thousand USD | 114444.137% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -5777.987% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 945.916% |
| AnaptysBio, Inc. | -18.15 Million USD | -640.934% |
| Design Therapeutics, Inc. | -18.15 Million USD | -640.975% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -91.084% |
| NeurAxis, Inc. | 145.7 Thousand USD | 92404.049% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1297.356% |
| Lumos Pharma, Inc. | -28.49 Million USD | -372.0% |
| Achilles Therapeutics plc | -126.92 Million USD | -5.959% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -87.457% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -20409.508% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -547.387% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 9323.271% |
| Nutriband Inc. | -251.65 Thousand USD | -53340.596% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -921.084% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1707.621% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 139.532% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 666.619% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 69.945% |
| Palisade Bio, Inc. | -12.06 Million USD | -1014.872% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 4.151% |
| Beam Therapeutics Inc. | -262.72 Million USD | 48.81% |
| Neurogene Inc. | -131.95 Million USD | -1.919% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 716.46% |
| AEON Biopharma, Inc. | -4.88 Million USD | -2655.881% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 64.345% |
| Sesen Bio, Inc. | -112.55 Million USD | -19.488% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -34.676% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -5628.231% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -244.609% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -61.484% |
| Athira Pharma, Inc. | -88.99 Million USD | -51.111% |
| Vaccinex, Inc. | -1.28 Million USD | -10341.537% |
| HCW Biologics Inc. | 2.85 Million USD | 4807.814% |
| XOMA Corporation | -29 Million USD | -363.748% |
| Nektar Therapeutics | 210.24 Million USD | 163.968% |
| Arvinas, Inc. | -313.8 Million USD | 57.142% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 8386.883% |
| Merus N.V. | -192.88 Million USD | 30.276% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 324.201% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -1838.412% |
| Rezolute, Inc. | -68.16 Million USD | -97.288% |
| Clene Inc. | 3.34 Million USD | 4126.557% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -919.845% |
| BeyondSpring Inc. | -13.75 Million USD | -877.732% |
| Synlogic, Inc. | -6.68 Million USD | -1911.773% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 11959.524% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1490.621% |
| Peak Bio, Inc. | 10.34 Million USD | 1400.628% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -63.173% |
| Krystal Biotech, Inc. | -350.23 Million USD | 61.601% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 208.348% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 20.42% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -4159.768% |
| MannKind Corporation | 143.89 Million USD | 193.459% |
| Ikena Oncology, Inc. | -109.15 Million USD | -23.206% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1676.344% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -306.305% |
| Gossamer Bio, Inc. | 180.35 Million USD | 174.568% |
| CohBar, Inc. | -5.93 Million USD | -2167.629% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -352.088% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3045.401% |
| Legend Biotech Corporation | -949.39 Million USD | 85.834% |
| Mural Oncology plc | -255.84 Million USD | 47.434% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 517.467% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -2754.961% |
| Disc Medicine, Inc. | -358.28 Million USD | 62.463% |
| Champions Oncology, Inc. | 4.81 Million USD | 2894.825% |
| REGENXBIO Inc. | 54.76 Million USD | 345.558% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -49912.458% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 10.95% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1392.309% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -66.686% |
| Vaxart, Inc. | -8.24 Million USD | -1531.926% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -168.009% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -5.757% |
| Cellectis S.A. | -43.85 Million USD | -206.663% |
| Longeveron Inc. | -2.9 Million USD | -4524.725% |
| Repare Therapeutics Inc. | -107.85 Million USD | -24.689% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 113.888% |
| Inozyme Pharma, Inc. | 12 Million USD | 1220.352% |
| Revolution Medicines, Inc. | -608.2 Million USD | 77.888% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -10833.902% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 49.273% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 10.385% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -759.507% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -18073.919% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.594% |
| Denali Therapeutics Inc. | -74.86 Million USD | -79.639% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1021.501% |
| Veru Inc. | 4.77 Million USD | 2913.554% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1095.865% |
| Cingulate Inc. | 3.08 Million USD | 4462.661% |
| Passage Bio, Inc. | 4.58 Million USD | 3033.195% |
| Context Therapeutics Inc. | -14.44 Million USD | -830.717% |
| Exicure, Inc. | 5.84 Million USD | 2399.316% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 41.623% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -239.871% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 957.096% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -128.638% |
| Nuvalent, Inc. | -335.38 Million USD | 59.901% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 7854.357% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -80.563% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1412.79% |
| OmniAb, Inc. | 9.2 Million USD | 1561.339% |
| Anew Medical, Inc. | 1.43 Million USD | 9488.502% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 920.956% |
| Lipocine Inc. | -4.75 Million USD | -2728.571% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -22.452% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 982.982% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -165.475% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 640.282% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -1900.997% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -104.304% |
| Ocugen, Inc. | -32.52 Million USD | -313.539% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -57.157% |
| Q32 Bio Inc. | -37.94 Million USD | -254.398% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -21315.127% |
| Alumis Inc. Common Stock | -13.52 Million USD | -894.065% |
| Equillium, Inc. | -22.39 Million USD | -500.603% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -425.997% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -312.198% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -54147.222% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 200.332% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 4305.347% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 41047.08% |
| Dominari Holdings Inc. | 195 Thousand USD | 69067.692% |
| Edesa Biotech, Inc. | -5.26 Million USD | -2453.433% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1408.209% |
| Bio-Techne Corporation | 267.74 Million USD | 150.229% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -729.706% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -13.881% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1500.464% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -963.054% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 45.134% |
| Nkarta, Inc. | 57.29 Million USD | 334.711% |
| BioCardia, Inc. | 212 Thousand USD | 63537.264% |
| Iterum Therapeutics plc | 13.43 Million USD | 1100.796% |